# EDGAR Filing Document

**Accession Number:** 0001873875
**File Stem:** 0001213900-25-110267
**Filing Date:** 2025-11
**Character Count:** 20118
**Document Hash:** 64202de4f841c44338e0f42eed4cc874
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-110267.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001213900-25-110267

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**EFFECTIVENESS DATE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Incannex Healthcare Inc.
- **CENTRAL INDEX KEY:** 0001873875
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-291526
- **FILM NUMBER:** 251480864

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 8 CENTURY CIRCUIT
- **STREET 2:** STE. 105
- **CITY:** NORWEST NSW
- **NON US STATE TERRITORY:** NSW
- **PROVINCE COUNTRY:** C3
- **BUSINESS PHONE:** 61 409 840 786

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 8 CENTURY CIRCUIT
- **STREET 2:** STE. 105
- **CITY:** NORWEST NSW
- **NON US STATE TERRITORY:** NSW
- **PROVINCE COUNTRY:** C3

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Incannex Healthcare Ltd
- **DATE OF NAME CHANGE:** 20210720

**As filed with the Securities and Exchange Commission on November 14, 2025**

**REGISTRATION NO. 333 -**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

**under the**

**SECURITIES ACT OF 1933**

**Incannex Healthcare Inc.**

(*Exact name of Registrant as specified in its charter)*

 

---

| | |
|:---|:---|
| **Delaware** | **93-2403210** |
| *(State or other jurisdiction of <br> incorporation or organization)* | *(I.R.S. Employer<br> Identification No.)* |

---

**Rialto South Tower**

**Level 23, 525 Collins Street**

**Melbourne VIC 3008<br> Australia**

(*Address of Principal Executive Offices*)*(Zip Code)*

**Incannex Healthcare Inc. 2023 Equity Incentive Plan**

*(Full titles of the plan(s))*

**Joel Latham**

**Chief Executive Officer and President**

**Incannex Healthcare Inc.**

**Rialto South Tower**

**Level 23, 525 Collins Street**

**Melbourne VIC 3008<br> Australia**

**+61 409 840 786**

(*Name, address and telephone number, including area code, of agent for service*)

*Copies to:*

**Scott M. Stanton, Esq.**

**Melanie Ruthrauff Levy, Esq.**

**Jason Miller, Esq.**

**Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC**

**3580 Carmel Mountain Road, Suite 300**

**San Diego, CA 92030**

**858-314-1873**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**<u>EXPLANATORY NOTE</u>**

This Registration Statement on Form S-8 is being filed with the U.S. Securities and Exchange Commission (the "SEC") for the purpose of registering an additional 69,541,101 shares of common stock of Incannex Healthcare Inc. (the "Registrant") issuable, or which may become issuable, under the Incannex Healthcare Inc. 2023 Equity Incentive Plan as amended by that certain amendment dated May 27, 2025 (as amended, the "2023 Plan") pursuant to the "evergreen" provision of such plan.

Pursuant to General Instruction E on Form S-8, the contents of the prior registration statements on Form S-8, File Nos. 333-276172 and 333-287786, previously filed with respect to the 2023 Plan, are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.

**PART I**

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS**

The documents containing the information specified in Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) of the Securities Act of 1933, as amended (the "Securities Act"). These documents and the documents incorporated by reference into this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3. Incorporation of Documents by Reference.**

The following documents filed by the Registrant with the SEC are incorporated herein by reference:

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Registrant's Annual
Report on [Form 10-K](http://www.sec.gov/ix?doc=/Archives/edgar/data/1873875/000121390025092837/ea0258594-10k_incannex.htm) for the fiscal year ended June 30, 2025 filed with the SEC on September
29, 2025 ;

&nbsp;&nbsp;&nbsp;&nbsp;(b) The Registrant's Current
Reports on Form 8-K filed with the SEC on [July 24, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/1873875/000121390025067374/ea0250044-8k_incannex.htm) , [July 25, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/1873875/000121390025067474/ea0250114-8k_incannex.htm) , [July 30, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/1873875/000121390025068954/ea0250564-8k_incannex.htm) , [July 31, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/1873875/000121390025069638/ea0251027-8k_incannex.htm) , [August 8, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/1873875/000121390025073321/ea0252400-8k_incannex.htm) , [August 22, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/1873875/000121390025079600/ea0254125-8k_incannex.htm) , [August 26, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/1873875/000121390025080509/ea0254452-8k_incannex.htm) ; [October 22, 2025](http://www.sec.gov/Archives/edgar/data/1873875/000121390025100980/ea0262074-8k_incannex.htm) , [October 22, 2025](http://www.sec.gov/Archives/edgar/data/1873875/000121390025100985/ea0262073-8k_incannex.htm) , [October 30, 2025](http://www.sec.gov/Archives/edgar/data/1873875/000121390025103780/ea0262765-8k_incannex.htm) ; and

&nbsp;&nbsp;&nbsp;&nbsp;(c) the description of the common
stock contained in [Exhibit 4.1](https://www.sec.gov/Archives/edgar/data/1873875/000121390025092837/ea025859401ex4-1_incannex.htm) of the Registrant's Annual Report on [Form 10-K](http://www.sec.gov/ix?doc=/Archives/edgar/data/1873875/000121390025092837/ea0258594-10k_incannex.htm) filed with the SEC on September
29, 2025 , including any amendments or reports filed for the purpose of updating such description.

In addition, all documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the filing of this registration statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold shall be deemed to be incorporated by reference into this registration statement and to be a part hereof from the date of filing such documents, except as to specific sections of such statements as set forth therein. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement contained herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained in any subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.

Under no circumstances shall any information furnished under Item 2.02 or 7.01 of Current Report on Form 8-K be deemed incorporated herein by reference unless such Current Report on Form 8-K expressly provides to the contrary.

**Item 8. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 3.1 | [Certificate of Amendment to Amended and Restated Certificate of Incorporation of Incannex Healthcare Inc., dated May 27, 2025 (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K filed with the SEC on May 28, 2025).](https://www.sec.gov/Archives/edgar/data/0001873875/000121390025047988/ea024345901ex3-1_incannex.htm) |
| 3.2 | [Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on July 31, 2023 (incorporated by reference to Exhibit 3.1 of the Company's Current Report on Form 8-K filed with the SEC on November 29, 2023)](http://www.sec.gov/Archives/edgar/data/1873875/000121390023091083/ea189032ex3-1_incannex.htm) |
| 3.3 | [Amended and Restated Bylaws, dated November 20, 2023 (incorporated by reference to Exhibit 3.2 of the Company's Current Report on Form 8-K filed with the SEC on November 29, 2023)](http://www.sec.gov/Archives/edgar/data/1873875/000121390023091083/ea189032ex3-2_incannex.htm) |
| 5.1\* | <u>[Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.](ea026543401ex5-1_incannex.htm)</u> |
| 23.1\* | [Consent of Grant Thornton](ea026543401ex23-1_incannex.htm) |
| 23.2\* | <u>[Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (contained in Exhibit 5.1 hereto)](ea026543401ex5-1_incannex.htm)</u> |
| 24.1\* | [Power of Attorney (included on signature page)](#a_019) |
| 99.1 | [Amendment No. 1 to Incannex Healthcare Inc. 2023 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 of the Company's Registration Statement on Form S-8 filed with the SEC on June 4, 2025)](http://www.sec.gov/Archives/edgar/data/1873875/000121390025051246/ea024412101ex99-1_incannex.htm) |
| 99.2 | [Incannex Healthcare Inc. 2023 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 of the Company's Current Report on Form 8-K filed with the SEC on November 29, 2023)](http://www.sec.gov/Archives/edgar/data/1873875/000121390023091083/ea189032ex10-2_incannex.htm) |
| 107\* | <u>[Filing Fee Table](ea026543401ex-fee_incannex.htm)</u> |

---

\* Filed herewith.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in Melbourne, Victoria, Australia on the 14th day of November, 2025.

---

| | |
|:---|:---|
| **INCANNEX HEALTHCARE INC.** | **INCANNEX HEALTHCARE INC.** |
| By: | /s/ Joel Latham |
| Name: | Joel Latham |
| Title: | Chief Executive Officer, President and Director |

---

**POWER OF ATTORNEY AND SIGNATURES**

We, the undersigned officers and directors of Incannex Healthcare Inc., hereby severally constitute and appoint Joel Latham and Joseph Swan, and each of them individually, our true and lawful attorney to sign for us and in our names in the capacities indicated below any and all amendments or supplements, including any post-effective amendments, to this registration statement on Form S-8 and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming our signatures to said amendments to this registration statement signed by our said attorney and all else that said attorney may lawfully do and cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this registration statement on Form S-8 has been signed below by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Person** | **Capacity** | **Date** |
| /s/ Joel Latham | Chief Executive Officer, President and Director | November 14, 2025 |
| Joel Latham | (Principal Executive Officer) |  |
| /s/ Joseph Swan | Chief Financial Officer | November 14, 2025 |
| Joseph Swan | (Principal Financial and Accounting Officer) |  |
| /s/ Troy Valentine | Chairman | November 14, 2025 |
| Troy Valentine |  |  |
| /s/ Peter Widdows | Director | November 14, 2025 |
| Peter Widdows |  |  |
| /s/ George Anastassov | Director | November 14, 2025 |
| George Anastassov |  |  |
| /s/ Robert Clark | Director | November 14, 2025 |
| Robert Clark |  |  |

---

## Exhibit 5.1

**Exhibit 5.1**

---

| | |
|:---|:---|
| ![](ex5-1_001.jpg) | 3580 Carmel Mountain Road<br> Suite 300<br> San Diego, CA 92130 <br> 858 314 1500<br> mintz.com |

---

November 14, 2025

Incannex Healthcare Inc.

Rialto South Tower

Level 23, 525 Collins Street

Melbourne VIC 3008<br> Australia

Ladies and Gentlemen:

We have acted as legal counsel to Incannex Healthcare Inc., a Delaware corporation (the "Company"), in connection with the preparation and filing with the U.S. Securities and Exchange Commission (the "Commission") of a Registration Statement on Form S-8 (the "Registration Statement"), pursuant to which the Company is registering the issuance under the Securities Act of 1933, as amended (the "Securities Act"), of an aggregate of 69,541,101 shares (the "Shares") of the Company's common stock, $0.0001 par value per share, in accordance with the terms of the Incannex Healthcare Inc. 2023 Equity Incentive Plan, as amended by that certain amendment dated May 27, 2025 (as amended, the "2023 Plan"). This opinion is being rendered in connection with the filing of the Registration Statement with the Commission.

In connection with this opinion, we have examined the Company's Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, each as currently in effect and as amended to date; such other records of the corporate proceedings of the Company and certificates of the Company's officers as we have deemed relevant; and the Registration Statement and the exhibits thereto.

In our examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies, the authenticity of the originals of such copies, and the truth and correctness of any representations and warranties contained therein. In addition, we have assumed that the Company will receive any required consideration in accordance with the terms of the 2023 Plan.

Our opinion expressed herein is limited to the General Corporation Law of the State of Delaware and we express no opinion with respect to the laws of any other jurisdiction. No opinion is expressed herein with respect to the qualification of the Shares under the securities or blue-sky laws of any state or any foreign jurisdiction.

Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, and we disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or opinions set forth herein.

Based upon the foregoing, we are of the opinion that the Shares, when issued and delivered in accordance with the terms of the 2023 Plan, will be validly issued, fully paid and non-assessable.

Boston Los Angeles MIAMI New York San Diego San Francisco TORONTO Washington

**MINTZ**

---

| | |
|:---|:---|
| November 14, 2025<br> Page 2 | ![](ex5-1_001.jpg) |

---

We understand that you wish to file this opinion with the Commission as an exhibit to the Registration Statement in accordance with the requirements of Item 601(b)(5) of Regulation S-K promulgated under the Securities Act, and we hereby consent thereto. In giving this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

---

| |
|:---|
| Very truly yours, |
| /s/ Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
| Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |

---

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We have issued our report dated September 29, 2025 with respect to the consolidated financial statements of Incannex Healthcare Inc. included in the Annual Report on Form 10-K for the year ended June 30, 2025, which are incorporated by reference in this Registration Statement. We consent to the incorporation by reference of the aforementioned report in this Registration Statement.

/s/ GRANT THORNTON AUDIT PTY LTD

Perth, Australia

November 14, 2025

## Ex-Filing

?xml version='1.0' encoding='ASCII'? Filing Fee Exhibit

**Ex-Filing Fees**

**CALCULATION OF FILING FEE TABLES**

**S-8**

**Incannex Healthcare Inc.**

**Table 1: Newly Registered Securities**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Notes** | **Fee Calculation<br> Rule** | **Amount Registered** | **Proposed Maximum Offering<br> Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| Equity | Common Stock, par value $0.0001 per share | (1) | Other | 69541101 | $0.3602 | $25048704.58 | 0.0001381 | $3459.23 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | $25048704.58 |  | 3459.23 |
| Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: |  |  | 0.00 |
| Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: |  |  | $3459.23 |

---

**__________________________________________ Offering Note(s)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers an indeterminate number of additional shares of common stock, par value $0.0001 per share ("Common Stock"), of Incannex Healthcare Inc., which may be subject to grant or otherwise issuable after the operation of any anti-dilution and other provisions of the Incannex Healthcare Inc. 2023 Equity Incentive Plan, as amended by that certain amendment dated May 27, 2025 (as amended, the "2023 Plan") Represents an increase, pursuant to the "evergreen" provision of the 2023 Plan, of 69,541,101 shares of Common Stock authorized for issuance under the 2023 Plan. Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) promulgated under the Securities Act. The offering price per share and the aggregate offering price are based on the average of the high and the low price of Common Stock as reported on The Nasdaq Capital Market as of a date (November 10, 2025) within five business days prior to filing this Registration Statement.